COMMUNIQUÉS West-GlobeNewswire

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités
15/05/2024
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2023 ET LES EVENEMENTS CLEFS DE LA PERIODE Développement clinique Poursuite des procédures de demande d’autorisation [...]
60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
15/05/2024
Q1 2024 net product revenues increased 515% year-over-year to $105.7 thousand. Gross profit increased from ($55.9 thousand) to $51.0 thousand. WASHINGTON, May 15, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc [...]
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
15/05/2024
DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- New research from The Cooper Institute® and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at [...]
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
15/05/2024
MOUNTAIN VIEW, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the data from its REVEALPLAQUE study, [...]
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
15/05/2024
PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15, 2024, at 6.00 pm CEST Accelerated clinical efforts to roll-out PHAXIAM’s strategy in order to create a [...]
PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024
15/05/2024
PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024 Webinaire (en français) ce jour à 18h00 : inscrivez-vous ici Accélération des développements cliniques en [...]
Ezra Partners with Princeton Radiology for Proactive, Whole-Body MRI Screenings to Support Earlier Cancer Detection
15/05/2024
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Ezra , the healthcare AI startup transforming early cancer detection through full body MRI screening, today announced a new partnership with Princeton Radiology Associates, [...]
Mathew Hall, Sarcoidosis Warrior, Takes on Iron Man 70.3 Chattanooga to Raise Awareness and Support for Sarcoidosis
15/05/2024
CHICAGO, May 15, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) proudly announces Mathew Hall, a devoted supporter and sarcoidosis patient, will be competing in the upcoming Ironman 70.3 [...]
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
15/05/2024
Primary results of the Scemblix ® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the EHA Plenary Session [...]
Dew Aesthetics Unveils Cutting-Edge MedSpa Treatments in Baltimore, Pioneering a Path to Timeless Beauty
15/05/2024
BALTIMORE, Md., May 15, 2024 (GLOBE NEWSWIRE) -- Dew Aesthetics , the premier destination for cutting-edge medical spa treatments, is proud to announce the launch of its innovative services, revolutionizing the [...]
Dr. Bob Meyer D.C. Legacy in Sports Medicine Continues to Shine Bright: A Testament to Excellence
15/05/2024
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- In the fast-paced world of sports medicine, few names command as much respect and admiration as Dr. Bob Meyer, D.C. With a career spanning decades, Dr. Bob has not only [...]
Alvotech S.A. Annual General Meeting to be held June 7, 2024
15/05/2024
The Annual General Meeting of Alvotech S.A. will be held on Friday June 7, 2024, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand Duchy of [...]
Vaso Corporation Announces Financial Results for First Quarter 2024
15/05/2024
PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. “Total revenue for the first quarter of 2024 was [...]
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
15/05/2024
Planegg/Martinsried, May 15, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
Promex Broadens Leadership Team Expertise, Naming Matt Hansen Director of Sales and Business Development
15/05/2024
Hansen to leverage breadth of industry experience in targeting new markets SANTA CLARA, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Promex Industries , a Silicon Valley-based provider of advanced design, packaging and [...]
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
15/05/2024
ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to [...]
CloudMD Announces Go-Private Transaction with CPS Capital
15/05/2024
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, and [...]
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement
15/05/2024
BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to [...]
ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
15/05/2024
Key Highlights: Second research site selected to enhance enrollment in the Phase 2a clinical trial for Cholesterol Efflux Mediator TM VAR 200 in patients with diabetic kidney disease planned to begin H1-2024. GLP [...]

Pages